The US is the bigger Blood Gas and Electrolyte Analyzers market: $1.2 Bn against $225 Mn in 2023, about 5.2 times as large.
China grows faster: 7.9% a year, against 4.4%. The gap still grows from $951 Mn to $1.3 Bn by 2033.
Clinical research: 216 active trials in the US, 137 in China.
| Measure |  US |  China |
|---|---|---|
| Market size, 2023 | $1.2 Bn | $225 Mn |
| Market size, 2033 projected | $1.8 Bn | $482 Mn |
| Growth a year (CAGR) | 4.4% | 7.9% |
| Money added, 2023–2033 | $633 Mn | $256 Mn |
| Share of the world market | 42% | 8% |
| Size rank of 24 countries | #1 | #2 |
| Market per person, 2023 | $3.44 | $0.16 |
| Active clinical trials | 216 | 137 |
| Full report | US report | China report |
Year by year, 2023 to 2033
US China · values between 2023 and 2033 are projected from the 2023 size and the CAGR.
Quick answers
Which is bigger in Blood Gas and Electrolyte Analyzers, US or China?
The US is the bigger Blood Gas and Electrolyte Analyzers market: $1.2 Bn against $225 Mn in 2023, about 5.2 times as large.
Which grows faster in Blood Gas and Electrolyte Analyzers, US or China?
China grows faster: 7.9% a year, against 4.4%. The gap still grows from $951 Mn to $1.3 Bn by 2033.
More Blood Gas and Electrolyte Analyzers comparisons
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Population: World Bank.